Natural killer cell-derived extracellular vesicles in cancer therapy
- PMID: 32697853
- DOI: 10.1111/sji.12938
Natural killer cell-derived extracellular vesicles in cancer therapy
Abstract
Cancer is a major cause of death in the industrialized world. New therapies are constantly being developed in order to reduce morbidity and mortality. NK cell-based cellular therapies have shown effect against haematological malignancies, but it has been difficult to target solid tumours due to low NK cell infiltration of the tumour and efficient tumour evasion strategies. NK cells release extracellular vesicles that naturally contain cytolytic proteins and tumour-targeting molecules. These vesicles can directly interact with and kill malignant cells, and their small size could allow more efficient extravasation into the tumour tissue. Extracellular vesicles are also less sensitive to the hostile tumour microenvironment compared to cells. Based on their features, NK cell-derived extracellular vesicles represent promising novel tools in oncology. In this review, we summarize the current available literature on NK cell-derived extracellular vesicles and discuss how they may be utilized in therapy for solid tumours.
Keywords: NK cells; cancer; extracellular vesicles.
© 2020 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology.
Similar articles
-
Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.Biomaterials. 2019 Jan;190-191:38-50. doi: 10.1016/j.biomaterials.2018.10.034. Epub 2018 Oct 29. Biomaterials. 2019. PMID: 30391801
-
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.Front Immunol. 2019 May 31;10:1205. doi: 10.3389/fimmu.2019.01205. eCollection 2019. Front Immunol. 2019. PMID: 31214177 Free PMC article. Review.
-
Cancer extracellular vesicles as novel regulators of NK cell response.Cytokine Growth Factor Rev. 2020 Feb;51:19-26. doi: 10.1016/j.cytogfr.2019.11.007. Epub 2019 Nov 30. Cytokine Growth Factor Rev. 2020. PMID: 31837917 Review.
-
Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells.Exp Cell Res. 2018 Feb 15;363(2):141-150. doi: 10.1016/j.yexcr.2017.12.005. Epub 2017 Dec 19. Exp Cell Res. 2018. PMID: 29269076
-
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity.Trends Immunol. 2003 Nov;24(11):603-9. doi: 10.1016/j.it.2003.09.007. Trends Immunol. 2003. PMID: 14596885 Review.
Cited by
-
NK3.3-Derived Extracellular Vesicles Penetrate and Selectively Kill Treatment-Resistant Tumor Cells.Cancers (Basel). 2023 Dec 23;16(1):90. doi: 10.3390/cancers16010090. Cancers (Basel). 2023. PMID: 38201518 Free PMC article.
-
Roles of extracellular vesicles in glioblastoma: foes, friends and informers.Front Oncol. 2023 Nov 24;13:1291177. doi: 10.3389/fonc.2023.1291177. eCollection 2023. Front Oncol. 2023. PMID: 38074665 Free PMC article. Review.
-
A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.J Extracell Vesicles. 2023 Dec;12(12):e12387. doi: 10.1002/jev2.12387. J Extracell Vesicles. 2023. PMID: 38054534 Free PMC article.
-
Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.Front Immunol. 2023 Sep 25;14:1265101. doi: 10.3389/fimmu.2023.1265101. eCollection 2023. Front Immunol. 2023. PMID: 37818374 Free PMC article.
-
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art.Cancer Cell Int. 2023 Aug 5;23(1):157. doi: 10.1186/s12935-023-02996-6. Cancer Cell Int. 2023. PMID: 37543612 Free PMC article. Review.
References
REFERENCES
-
- Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013;31:227-258.
-
- Pahl J, Cerwenka A. Tricking the balance: NK cells in anti-cancer immunity. Immunobiology. 2017;222(1):11-20.
-
- Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006;6(7):520-531.
-
- Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today. 1990;11(7):237-244.
-
- Malmberg KJ, Bryceson YT, Carlsten M, et al. NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother. 2008;57(10):1541-1552.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
